Copy Number Variation in CHRNA7 Gene in Migraine and Gene Expression

NCT04912752 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2021-06-03

No results posted yet for this study

Summary

Migraine is a common and possible hereditary disease. Copy number variation (CNV) is a phenomenon in which parts of the genome are repeated and the number of repeats in the genome varies between individuals in the human population.The CHRNA7 gene has a major role in the neuropsychiatric phenotypes observed in patients. The 15q13.3 gain/loss variation in this gene may be associated with migraine.

Conditions

Interventions

GENETIC

Migraine CNV

Copy number variation effect on migraine disease

Sponsors & Collaborators

  • University of Gaziantep

    lead OTHER

Principal Investigators

  • Mehmet Fatih Özaltun, MD · Assist

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-05
Primary Completion
2020-12-10
Completion
2021-01-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04912752 on ClinicalTrials.gov